Fingerprint
Dive into the research topics of 'Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL—a matched cohort analysis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL—a matched cohort analysis
Irit Avivi, Chava Perry, Yafit Segman, Odelia Amit, Yaeli Bar-On, Ofrat Beyer Katz, Ronit Gold, Elena Ribakovsky, Abraham Avigdor, Vladimir Vainstein, Neta Goldschmidt, Shimrit Ringelstein-Harlev, Netanel A. Horowitz, Odit Gutwein, Ronit Gurion, Gilad Itchaki, Uri Abadi, Anatoly Nemets, Orit Sofer, Miri Vezker
*Corresponding author for this work
- Tel Aviv University
- Hadassah University Medical Centre
- General Directorate Rambam Health Care Campus
- Assaf Harofeh Medical Center
- Rabin Medical Center Israel
- Meir Hospital Sapir Medical Center
- Barzilai Medical Center
- Hille Yaffe Medical Center Israel
- Soroka Medical Center
- Bnai-Zion Medical Center
- Rebecca Sieff Government Hospital
- Kaplan Medical Center Israel
- Assuta Medical Center
Research output: Contribution to journal › Article › peer-review
3
Scopus
citations